| |
Latest 10 SEC filings (by transaction date) for ATRA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 2/24 | Mar 31/24 | Fust Matthew K | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Apr 2/24 | Mar 31/24 | Heiden William K | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Apr 2/24 | Mar 31/24 | Roncarolo Maria Grazia | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Apr 2/24 | Mar 31/24 | Gallagher Carol Giltner | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Apr 2/24 | Mar 31/24 | Mallik Ameet | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Mar 6/24 | Mar 4/24 | Touchon Pascal | Direct Ownership | Common Stock | S - Open market or private sale | -24,844 | $0.720 |
Jan 9/24 | Jan 8/24 | Touchon Pascal | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 1,280,000 | |
Jan 9/24 | Jan 8/24 | Nguyen AnhCo | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 675,000 | |
Jan 9/24 | Jan 8/24 | Murugan Amar | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 475,000 | |
Jan 9/24 | Jan 8/24 | Hyllengren Eric J | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 475,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ATRA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 2/24 | Mar 31/24 | Fust Matthew K | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Apr 2/24 | Mar 31/24 | Heiden William K | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Apr 2/24 | Mar 31/24 | Roncarolo Maria Grazia | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Apr 2/24 | Mar 31/24 | Gallagher Carol Giltner | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Apr 2/24 | Mar 31/24 | Mallik Ameet | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 150,000 | |
Mar 6/24 | Mar 4/24 | Touchon Pascal | Direct Ownership | Common Stock | S - Open market or private sale | -24,844 | $0.720 |
Jan 9/24 | Jan 8/24 | Touchon Pascal | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 1,280,000 | |
Jan 9/24 | Jan 8/24 | Nguyen AnhCo | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 675,000 | |
Jan 9/24 | Jan 8/24 | Murugan Amar | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 475,000 | |
Jan 9/24 | Jan 8/24 | Hyllengren Eric J | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 475,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |